Literature DB >> 19484261

Tenascin C in medullary thyroid microcarcinoma and C-cell hyperplasia.

Oskar Koperek1, Astrid Prinz, Christian Scheuba, Bruno Niederle, Klaus Kaserer.   

Abstract

Tenascin C (Tn-C) is an extracellular matrix glycoprotein that is expressed early in carcinogenesis including intraepithelial neoplastic lesions of different organs. In this study, we analyze whether stroma reaction seen by Tn-C expression is detected early in tumorigenesis of medullary thyroid carcinoma (MTC) including medullary microcarcinoma and C-cell hyperplasia (CCH), which is accepted to be a precursor lesion of MTC in the setting of RET oncogene germ-line mutation. Tn-C was expressed in the stroma of all medullary microcarcinoma and in the stroma next to CCH. Stromal Tn-C expression was significantly more often seen in CCH with concomitant MTC than in isolated CCH of hereditary as well as nonhereditary cases (p = 0.001 and p = 0.016, respectively). We conclude that Tn-C expression and thus early stroma remodeling is seen in medullary microcarcinoma and CCH. Stromal Tn-C expression seems to be an indicator of a further step in carcinogenesis of MTC irrespective of a RET oncogene germ-line mutation.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19484261     DOI: 10.1007/s00428-009-0786-y

Source DB:  PubMed          Journal:  Virchows Arch        ISSN: 0945-6317            Impact factor:   4.064


  38 in total

1.  Extracellular matrix and tenascin-C in pathogenesis of breast cancer.

Authors:  P L Jones
Journal:  Lancet       Date:  2001-06-23       Impact factor: 79.321

2.  Histopathological and molecular studies in patients with goiter and hypercalcitoninemia: reactive or neoplastic C-cell hyperplasia?

Authors:  Uberta Verga; Stefano Ferrero; Leonardo Vicentini; Tatiana Brambilla; Valentina Cirello; Marina Muzza; Paolo Beck-Peccoz; Laura Fugazzola
Journal:  Endocr Relat Cancer       Date:  2007-06       Impact factor: 5.678

3.  C-cell hyperplasia and medullary thyroid carcinoma in patients routinely screened for serum calcitonin.

Authors:  K Kaserer; C Scheuba; N Neuhold; A Weinhäusel; H Vierhapper; O A Haas; B Niederle
Journal:  Am J Surg Pathol       Date:  1998-06       Impact factor: 6.394

4.  Sporadic versus familial medullary thyroid microcarcinoma: a histopathologic study of 50 consecutive patients.

Authors:  K Kaserer; C Scheuba; N Neuhold; A Weinhäusel; O A Haas; H Vierhapper; B Niederle
Journal:  Am J Surg Pathol       Date:  2001-10       Impact factor: 6.394

5.  Inherited medullary microcarcinoma of the thyroid: a study of 11 cases.

Authors:  J E Krueger; A Maitra; J Albores-Saavedra
Journal:  Am J Surg Pathol       Date:  2000-06       Impact factor: 6.394

Review 6.  Molecules in focus: tenascin-C.

Authors:  E J Mackie
Journal:  Int J Biochem Cell Biol       Date:  1997-10       Impact factor: 5.085

7.  Differential distribution of tenascin in the normal, hyperplastic, and neoplastic breast.

Authors:  A A Howeedy; I Virtanen; L Laitinen; N S Gould; G K Koukoulis; V E Gould
Journal:  Lab Invest       Date:  1990-12       Impact factor: 5.662

8.  Sporadic hypercalcitoninemia: clinical and therapeutic consequences.

Authors:  C Scheuba; K Kaserer; A Moritz; R Drosten; H Vierhapper; C Bieglmayer; O A Haas; B Niederle
Journal:  Endocr Relat Cancer       Date:  2008-11-05       Impact factor: 5.678

Review 9.  Tenascin in connective tissue development and pathogenesis.

Authors:  E J Mackie
Journal:  Perspect Dev Neurobiol       Date:  1994

10.  Pentagastrin stimulation test and early diagnosis of medullary thyroid carcinoma using an immunoradiometric assay of calcitonin: comparison with genetic screening in hereditary medullary thyroid carcinoma.

Authors:  N Barbot; C Calmettes; I Schuffenecker; J P Saint-André; B Franc; V Rohmer; P Jallet; J C Bigorgne
Journal:  J Clin Endocrinol Metab       Date:  1994-01       Impact factor: 5.958

View more
  4 in total

1.  Clinicopathological Significance and Prognosis of Medullary Thyroid Microcarcinoma: A Meta-analysis.

Authors:  Jin Hwa Kim; Jung-Soo Pyo; Won Jin Cho
Journal:  World J Surg       Date:  2017-10       Impact factor: 3.352

Review 2.  [Thyroid C cells and their pathology: Part 2: Medullary thyroid carcinoma].

Authors:  S Synoracki; S T Schmid; S Ting; K W Schmid
Journal:  Pathologe       Date:  2015-05       Impact factor: 1.011

3.  Expression of Tenascin C, EGFR, E-Cadherin, and TTF-1 in Medullary Thyroid Carcinoma and the Correlation with RET Mutation Status.

Authors:  Florian Steiner; Cornelia Hauser-Kronberger; Gundula Rendl; Margarida Rodrigues; Christian Pirich
Journal:  Int J Mol Sci       Date:  2016-07-09       Impact factor: 5.923

4.  Immunohistochemical Comparative Study of Aggressive and Non-aggressive Central Giant Cell Lesions of the Jaws Based on the Tenascin-C Expression Profile.

Authors:  Sergio Iván Tobón-Arroyave; Diana María Isaza-Guzmán; Gloria Amparo Flórez-Moreno
Journal:  J Histochem Cytochem       Date:  2021-06-14       Impact factor: 4.137

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.